Injection Pen Market to Reach US$ 41.38 billion by 2022 “Led by Diabetes, Osteoporosis and Fertility”
Injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, & therapies. The report analyzes injection pen market & aims at estimating market size & future growth potential of this market based on various segments such as type, therapy, end user, & region.
Pune, India – April 2, 2018 /MarketersMedia/ —
The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
Access Brochure of Injection Pen Market spread across 136 Pages, Profiling 12 Companies and Supported with 82 Tables and 40 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1367552 .
Global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine). The diabetes segment is expected to grow at the highest CAGR during the forecast period.
Key Target Audience:
• Injection pen manufacturing companies
• Original equipment manufacturing companies
• Suppliers and distributors of injection pen
• Healthcare service providers
• Teaching hospitals and academic medical centers
• Health insurance players
• Government bodies/municipal corporations
• Regulatory bodies
• Medical research institutes
• Business research and consulting service providers
• Venture capitalists
• Market research and consulting firms
The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.
Click Here for More Information on Injection Pen Market with Top Trends and Company Profile at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1367552 .
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.
Competitive Landscape
1 Overview
2 Market Ranking of OEM Companies
3 Market Share Analysis
4 Competitive Scenario
5 Product Launches
6 Regulatory Approvals
7 Expansions
8 Agreements, Collaborations, and Partnerships
9 Acquisitions
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Click Now for Discounted Copy of this Study “Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region – Global Forecast to 2022” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=1367552 .
The global injection pens market is dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France). Other prominent players in the market include Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
The high growth of this segment can be attributed to the large diabetic population across the globe and the favorable reimbursement scenario for diabetes treatments in developed countries.
Contact Info:
Name: Hrishikesh Patwardhan
Organization: ReportsandReports
Address: 2nd floor, metropole, Next to inox theatre, Bund garden road, Pune, Maharashtra, India
Phone: +1 888 391 5441
For more information, please visit http://www.reportsnreports.com/reports/1367552-injection-pen-market-by-type-disposable-and-reusable-pens-therapy-diabetes-insulin-glucagon-like-peptide-1-growth-hormone-therapy-osteoporosis-fertility-end-user-homecare-and-hospitals-and-region-gl-st-to-2022.html
Source: MarketersMedia
Release ID: 323871
Copyright © 1999-2013 SproutNews.com
